Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open‐label, parallel‐group, non‐inferiority Phase III trail

Chen, Nan; Xing, Changying; Niu, Jianying; Liu, Bicheng; Fu, Junzhou; Zhao, Jiuyang; Ni, Zhaohui; Wang, Mei; Liu, Wenhu; Zhao, Jinghong; Zhong, Ling; Wu, Xiongfei; Li, Wenge; Chen, Yuqing; Shi, Wei; Chen, Jianghua; Yin, Aiping; Fu, Ping; Wang, Rong; Jiang, Gengru; Hou, Fanfan; Ding, Guohua; Chen, Jing; Xu, Gang; Kondo, Yuichiro; Su, Yuliang; Mei, Changlin

Published in

Keai Publishing, Chronic Diseases and Translational Medicine, 1(8), p. 59-70, 2022

DOI: 10.1002/cdt3.13

Tools

Export citation

Search in Google Scholar

Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open‐label, parallel‐group, non‐inferiority Phase III trail

Journal article published in 2022 by Nan Chen, Changying Xing, Jianying Niu, Bicheng Liu, Junzhou Fu, Jiuyang Zhao, Zhaohui Ni, Mei Wang, Wenhu Liu, Jinghong Zhao, Ling Zhong, Xiongfei Wu, Wenge Li, Yuqing Chen, Wei Shi and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload

Policy details

Data provided by

Published in

Links

Tools

Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open‐label, parallel‐group, non‐inferiority Phase III trail